ATE489094T1 - Wässrige lösung mit einem camptothecin - Google Patents

Wässrige lösung mit einem camptothecin

Info

Publication number
ATE489094T1
ATE489094T1 AT05709954T AT05709954T ATE489094T1 AT E489094 T1 ATE489094 T1 AT E489094T1 AT 05709954 T AT05709954 T AT 05709954T AT 05709954 T AT05709954 T AT 05709954T AT E489094 T1 ATE489094 T1 AT E489094T1
Authority
AT
Austria
Prior art keywords
aqueous solution
camptothecin
solution containing
camptothecins
preparation containing
Prior art date
Application number
AT05709954T
Other languages
English (en)
Inventor
Masako Nakazawa
Ritsuo Aiyama
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Application granted granted Critical
Publication of ATE489094T1 publication Critical patent/ATE489094T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT05709954T 2004-02-13 2005-02-09 Wässrige lösung mit einem camptothecin ATE489094T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004035985 2004-02-13
JP2004035986 2004-02-13
PCT/JP2005/001902 WO2005077370A1 (ja) 2004-02-13 2005-02-09 カンプトテシン類含有水溶液製剤

Publications (1)

Publication Number Publication Date
ATE489094T1 true ATE489094T1 (de) 2010-12-15

Family

ID=34863456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05709954T ATE489094T1 (de) 2004-02-13 2005-02-09 Wässrige lösung mit einem camptothecin

Country Status (8)

Country Link
US (1) US20080242691A1 (de)
EP (1) EP1714653B1 (de)
JP (1) JP4451850B2 (de)
AT (1) ATE489094T1 (de)
CA (1) CA2556254A1 (de)
DE (1) DE602005024923D1 (de)
TW (1) TW200538457A (de)
WO (1) WO2005077370A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110177161A1 (en) * 2007-05-24 2011-07-21 Dr. Reddy's Laboratories Limited Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin
WO2009126950A2 (en) * 2008-04-11 2009-10-15 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Diterpene glycosides as natural solubilizers
EP2445535A4 (de) 2009-06-24 2014-12-17 Univ Louisiana State Terpen-glycoside und ihre kombinationen als lösungsmittel
US10098813B2 (en) 2014-09-03 2018-10-16 Sun Pharmaceutical Industries Limited Perfusion dosage form
IL261038B2 (en) 2016-02-09 2024-06-01 Sun Pharmaceutical Ind Ltd perfusion system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US5447936A (en) * 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
JP4094710B2 (ja) * 1997-11-06 2008-06-04 株式会社ヤクルト本社 新規なカンプトテシン誘導体
HUP0103314A3 (en) * 1998-08-05 2002-07-29 Aventis Pharma Sa Use of camptothecin derivatives, with reduced gastrointestinal toxicity
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
WO2001066123A2 (en) * 2000-03-09 2001-09-13 Yale University Composition consisting of phy906 and chemotherapeutic agents
US6653319B1 (en) * 2001-08-10 2003-11-25 University Of Kentucky Research Foundation Pharmaceutical formulation for poorly water soluble camptothecin analogues
TW200306314A (en) * 2002-04-16 2003-11-16 Tanabe Seiyaku Co Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation
US20060030578A1 (en) * 2002-08-20 2006-02-09 Neopharm, Inc. Pharmaceutically active lipid based formulation of irinotecan
JP4245384B2 (ja) 2003-03-18 2009-03-25 株式会社ヤクルト本社 カンプトテシン類含有医薬組成物

Also Published As

Publication number Publication date
US20080242691A1 (en) 2008-10-02
JPWO2005077370A1 (ja) 2007-10-18
EP1714653A1 (de) 2006-10-25
DE602005024923D1 (de) 2011-01-05
WO2005077370A1 (ja) 2005-08-25
JP4451850B2 (ja) 2010-04-14
EP1714653A4 (de) 2008-05-21
EP1714653B1 (de) 2010-11-24
CA2556254A1 (en) 2005-08-25
WO2005077370A8 (ja) 2006-01-05
TW200538457A (en) 2005-12-01

Similar Documents

Publication Publication Date Title
PT2305288T (pt) Preparações ácidas de insulina com estabilidade melhorada
WO2009079910A8 (zh) 促红细胞生成素模拟肽衍生物及其可药用盐和其制备方法与用途
CY1108593T1 (el) Συμπυκνωμενο υδατικο διαλυμα αμβροξολης
ATE355106T1 (de) Verbesserte kosmetische zusammensetzung mit vitamin b3, vitamin b6 und einer organischen säure
EP1595884A3 (de) Salz einer Sulfonsäure mit Clopidogrel und dessen Verwendung zur Herstellung pharmazeutischer Formulierungen
ATE326961T1 (de) Intranasale formulierung mit rotigotin
EP1640025A4 (de) Zusammensetzung zur topischen anwendung
ATE413812T1 (de) Hochlösliches sojaprotein von hohem molekulargewicht
WO2007005633A3 (en) Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
MXPA03011480A (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral.
MXPA04007068A (es) Derivados de almidon, conjugados de almidon con sustancia activa, metodo para su produccion y su uso como medicamentos.
WO2001087265A3 (de) Pharmazeutische darreichungsform für peptide, verfahren zu deren herstellung und verwendung
WO2002017921A3 (en) Paroxetine compositions and processes for making the same
WO2009019835A1 (ja) 生薬エキス配合液剤
ATE489094T1 (de) Wässrige lösung mit einem camptothecin
EA200800410A1 (ru) Золь-гель процесс
WO2008074488A3 (en) Construction and use of transfection enhancer elements
WO2004085387A3 (en) Water-soluble mono-pegylated tetrapyrrole derivatives for photodynamic therapy and method of production
WO2007018585A3 (en) Process for controlling protein to salt ratio in animal muscle protein composition and protein composition
ATE419012T1 (de) Verwendung von 2,5-dihydroxybenzolsulfonsäure- derivaten bei der herstellung eines medikaments zur verstärkung der wirkung anderer arzneimittel zur behandlung der erektilen dysfunktion
WO2004073646A3 (en) Treatment of pain through expression of opioid receptors
WO2008053206A3 (en) Process for preparation of aldonic acids and derivatives thereof
EP1625851A4 (de) Zubereitung zur verhinderung von kontakt von pathogen keimen mit einem lebenden organismus
ATE516015T1 (de) Galenische form zur oralen transmukosalen zuführung von triptanen
DE602004007762D1 (de) Herbizide zusammensetzung und verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties